We've spent the past several days reiterating and lamenting the onset of the holiday trading doldrums--a time of year that ...

Walmart (NYSE:WMT) is another US stock that exhibited classic signs of weakness around the same time as Pfizer (NYSE:PFE), but what is interesting here is the recent injection of volume which appeared ...

Bristol Myers Squibb (NYSE:BMY) was a stock I mentioned in my weekly stock webinar last week on the topic of stopping volume and I want to follow up on that here as it has developed into an excellent ...

Editor's note: This article was originally published in 2016 and has been updated for 2018. We practitioners of the technological arts have a tendency to use specialized jargon. That's not unusual.

This content has been created by the Finextra editorial team with inputs from subject matter experts at the funding sponsor. 15 years ago, innovation had stalled. Banks were licking their compliance ...

Government departments and CPSEs have continued to fail dismally in meeting targets for procuring from SC/ST and women-owned MSEs. Organisations that deliver the highest quality of service or products ...

Discover how quantity discounts lower per-unit costs for bulk purchases, their advantages like boosting sales, and potential ...

The mini-rally of August was positive for the stock, taking it from the VPOC at $140.70 per share, through stiff resistance as denoted with the red dashed line of the accumulation and distribution ...